
AstraZeneca PLC (AZN.L) Price-to-Earnings (P/E) Ratio
Price: $11316
Market Cap: $175.47B
Avg Volume: 2.74M
Market Cap: $175.47B
Avg Volume: 2.74M
Country: GB
Industry: Drug Manufacturers - General
Sector: Healthcare
Industry: Drug Manufacturers - General
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
AstraZeneca PLC's P/E ratios across different time periods:
- TTM: 32.36
- Annual: 28.93
- Quarterly: 33.92
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 4.99
- Price-to-Sales (P/S) Ratio: 3.76
Annual Ratios
AstraZeneca PLC Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
32.36
P/B Ratio (Annual)
4.99
P/S Ratio (Annual)
3.76
AstraZeneca PLC Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
Year | P/E Ratio | P/B Ratio | P/S Ratio |
---|---|---|---|
2024 | 28.93 | 4.99 | 3.76 |
2023 | 35.42 | 5.39 | 4.60 |
2022 | 63.83 | 5.67 | 4.73 |
2021 | 1486.79 | 4.24 | 4.45 |
2020 | 41.06 | 8.40 | 4.93 |
2019 | 98.23 | 9.99 | 5.38 |
2018 | 43.99 | 7.60 | 4.29 |
2017 | 29.18 | 5.85 | 3.90 |
2016 | 19.78 | 4.66 | 3.01 |
2015 | 30.43 | 4.65 | 3.48 |
2014 | 72.62 | 4.56 | 3.43 |
2013 | 29.01 | 3.19 | 2.88 |
2012 | 9.48 | 2.51 | 2.13 |
2011 | 6.31 | 2.71 | 1.87 |
2010 | 8.14 | 2.82 | 1.97 |
Related Metrics
Explore detailed financial metrics and analysis for AZN.L.